Loading...

457 posters, 2 videos, 2 audios, 8 topics, 45 sessions, 401 authors, 265 institutions

ePostersLive by SciGen Technologies S.A. All rights reserved.

49th Annual Regional Anesthesiology and Acute Pain Medicine Meeting

March 21-23, 2024 | The Hilton Bayfront San Diego | San Diego, California

49th Annual Regional Anesthesiology and Acute Pain Medicine Meeting banner

5295

FEMORAL NERVE CATHETER IMPROVES CPM COMPLIANCE AND LOWERS OPIOID USE VS. ADDUCTOR CANAL CATHETER AFTER ACL RECONSTRUCTION

Part of Topic

Scientific Abstracts > Regional Anesthesia

Femoral Catheter Marginally Improves CPM Compliance but Significantly Lowers Opioid Use vs Adductor Canal Catheter with ACL Repair

Aims
•Primary aims: Opioid Use and PainScores
•Secondary aims: Continuous Passive Motion Device (CPM) compliance for 48 hours after surgery andQuality of Recovery (QoR-15) score

Background
•Evidence shown by previous studies:
•Adductor Canal Block catheter(ACB) is non-inferior to Femoral Nerve Block catheter(FNB) analgesia after TotalKnee Arthroplasty [1].
•Single shot ACB is non-inferior to single shot FNB after ACL repair [2].
•ACB shows similar analgesia toFNB, with ACB betterpreserving quadriceps strength[3].
•Some surgeons have requested a FNBcatheter but not an ACB catheter for pain control after ACL reconstructiondue to a subjective impression of (1) better pain control, (2) less call back for poor pain control, and (3) less opioid refill requests.
•Hypothesis: FNB catheter will be superior to an ACB catheter after ACL reconstruction for pain control without negatively affecting the quality of recovery from potential transient quadriceps weakness.

Methods
•Double-blinded, RandomizedControlled Trial comparingFemoral Nerve Catheter with Adductor Canal Catheter.
•Standard ultrasound-guided femoral or adductor canal block catheter with a loading dose of 20mL 0.5% ropivacaine.
•Upon arrival to the recovery room, catheters were connected to portable infusion pump delivering a continuous infusion of 0.2% ropivacaine at 5mL/hr, with 5mL demand bolus and 30-minute lockout.
•Quality of Recovery questionnaire (QoR-15) conducted by phone at 24 and 48 hours after discharge from the recovery room.

Results
•Patients included: FNB = 28, ACB =29
•A significant association (p<0.05) exists between the FNB group and low opioid consumption, while the ACB group is associated with high opioid usage (p<0.05). 
•Within the FNB group, there were no patients, 0% (0/28), who had a high opioid consumption level of more than 50 MME/Day.Moreover, there were 50% (14/28) patients who had a low opioid usage level of less than 10 MME/Day in the FNB group. 
•In contrast, the ACB group included 17% (5/29) patients with high opioid usage and only 31% (9/29) patients with low opioid usage. 
•There were no differences between FNB and ACB catheters for CPMCompliance, pain scores, andQuality of Recovery (QoR-15) score.

Discussion
•No difference in pain scores and quality of recovery partly due to a dedicated team titrating opioids to desirable clinical effects for both groups.
•ACB was placed proximal to the junction of the distal femoral triangle and proximal adductor canal, on average 5 cm above the mid-thigh,measured as the mid-point between the ASIS and the patella.
•Despite the small difference between the 2 groups, the FNB catheterprevents the most severe pain.
•Limitation: No power to assess “fall”risk
 
References

1. Machi AT, Sztain JF, Kormylo NJ et al. Discharge readiness after tricompartment knee arthroplasty: Adductor canal versus femoral continuous nerve blocks-a dual-center, randomized trial. Anesthesiology 2015;123:444-56.

2. Abdallah FW, Whelan DB, Chan VW et al. Adductor canal block provides noninferior analgesia and superior quadriceps strength compared with femoral nerve block in anterior cruciate ligament reconstruction. Anesthesiology 2016;124:1053-64.

3. Jaeger P, Zaric D, Fomsgaard JS et al. Adductor canal block versus femoral nerve block for analgesia after total knee arthroplasty: A randomized, double-blind study. Reg Anesth Pain Med 2013;38:526-32.

49th Annual Regional Anesthesiology and Acute Pain Medicine Meeting » banner
Copyright © 2015-2026, ePostersLive® SciGen is a registered trademark of SciGen Technologies S.A. Patent pending.

This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.